Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Antiplatelet Removal and HemocompatIbility EventS with the HeartMate 3 Pump (ARIES HM3)
The ARIES HeartMate 3 Pump: Study for People with Advanced Heart Failure
Sponsor:Abbott Medical Devices
Enrolling:Male and Female Patients
Minimum Age:18 years old
IRB Number:AAAS9189
U.S. Government ID:NCT04069156
Contact: Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu
Additional Study Information:

The purpose of this research study is to understand if aspirin is needed in patients heart failure implanted with the HeartMate 3. Patients with devices like the HeartMate 3 take two blood thinner medicines, specifically warfarin and aspirin. Patients implanted with devices like the HeartMate 3 experience both clotting and bleeding complications. Data suggest the HeartMate 3 may not require as much anticoagulation (blood thinners) as are normally used. This study will test if patients need aspirin together with warfarin or just warfarin alone.

Do You Qualify?
Are you 18 years of age or older?YesNo
Submit
Cancel
Investigator
Nir Uriel, MD, MSc
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Kate Dalton
Email: keb2114@cumc.columbia.edu
Phone: 347-514-3366